Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 205731 | Eutelsat Communications SA (E3B.HM) | XHAM | FR | 2024-06-30 | 1 month ago | EUR | 5.91 | 9.65 | 163.23% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 205732 | Elicera Therapeutics AB (8E8.BE) | XBER | SE | 2024-12-31 | 5 days ago | SEK | 0.00 | 0.00 | 0.00% | 0.59 | 0.00% | Ungraded | 0.00 | 0.00% |
| 205733 | Norbit ASA (4NK.BE) | XBER | NO | 2024-12-31 | 1 month ago | NOK | 0.00 | 34.75 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 205734 | Prospect Resources Ltd (5E8.BE) | XBER | AU | 2024-06-30 | 5 days ago | AUD | 0.00 | 0.00 | 0.00% | 0.02 | 0.00% | Ungraded | 0.00 | 0.00% |
| 205735 | Phaxiam Therapeutics SA (2E40.BE) | XBER | FR | 2023-12-31 | 1 month ago | EUR | 1.90 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 205736 | Phaxiam Therapeutics SA (2E40.BE) | XBER | FR | 2023-12-31 | 1 month ago | EUR | 1.90 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 205737 | Core Scientific Inc (7ZD.BE) | XBER | US | 2024-12-31 | 5 days ago | USD | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 205738 | Sirohia & Sons Ltd (538667.BO) | XBOM | IN | 2024-03-31 | 1 month ago | INR | 11.77 | 0.00 | 0.00% | 23.37 | 198.58% | Ungraded | 0.00 | 0.00% |
| 205739 | Ganga Pharmaceuticals Ltd (539680.BO) | XBOM | IN | 2024-03-31 | 5 days ago | INR | 13.51 | 5.28 | 39.09% | 8.58 | 63.54% | Ungraded | 0.00 | 0.00% |
| 205740 | Nestle SA (NSTL.NE) | NEOE | CH | 2024-12-31 | 5 days ago | CHF | 0.00 | 35.21 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |